Printed From BioPortfolio.com
CRISPR Therapeutics Plans Its First Clinical Trial for Genetic Disease
14:08 EST 12 Dec 2017 | Bioethics.com
(Wired) – In the end, Crispr’s leading luminaries formed three companies—Caribou Biosciences, Editas Medicine, and Crispr Therapeutics—to take what they had done in their labs and use it to cure human disease. For nearly five years the “big three’ Crispr … Read More
Original Article: CRISPR Therapeutics Plans Its First Clinical Trial for Genetic Disease
